Related Experiment Video
Updated: Aug 7, 2026

Methods for Detecting Cytotoxic Amyloids Following Infection of Pulmonary Endothelial Cells by Pseudomonas aeruginosa
Published on: July 12, 2018
Nitrofurantoin can cause acute lung injury (pneumonopathy) in rare cases. This report details two such instances, discussing the drug
Area of Science:
- Pulmonary Medicine
- Pharmacology
- Toxicology
Background:
- Nitrofurantoin is a commonly prescribed antibiotic for urinary tract infections.
- Adverse pulmonary reactions, though uncommon, are a recognized side effect of nitrofurantoin therapy.
- Understanding these reactions is crucial for patient safety and appropriate clinical management.
Observation:
- Two distinct cases of acute pneumonopathy were observed in patients treated with nitrofurantoin.
- Clinical presentations included characteristic pulmonary symptoms and radiographic findings.
- Detailed analysis of the patient histories revealed a temporal association with nitrofurantoin administration.
Findings:
- The reported cases highlight the potential for nitrofurantoin to induce acute lung injury.
- Pathogenic mechanisms involve hypersensitivity reactions and direct drug toxicity.
- Diagnostic approaches include clinical evaluation, imaging, and exclusion of other causes.
Implications:
- Early recognition and discontinuation of nitrofurantoin are key to managing these pulmonary reactions.
- Awareness among healthcare providers can prevent misdiagnosis and delayed treatment.
- Further research into predictive factors and preventative strategies for nitrofurantoin-induced pneumonopathy is warranted.
More Related Videos
07:29The Left Pneumonectomy Combined with Monocrotaline or Sugen as a Model of Pulmonary Hypertension in Rats
Published on: March 8, 2019
10:26P. aeruginosa Infected 3D Co-Culture of Bronchial Epithelial Cells and Macrophages at Air-Liquid Interface for Preclinical Evaluation of Anti-Infectives
Published on: June 15, 2020
Related Concept Videos
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia II: Pathophysiology
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Pneumonia V: Nursing management and Prevention
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed.
Acute Pyelonephritis I: Introduction
Pneumonia I: Introduction